Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-26

Clinical Trial Update: Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assesses whether buprenorphine can help achieve remission in late-life major depressive disorder/depression after incomplete response…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Major Depressive Disorder, Depression | Phase 1, Phase 2 | Status: COMPLETED